Scarica l'app Stockscreener
96.37
1.61%
1.53
Dopo l'orario di chiusura:
96.05
-0.32
-0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LRCX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$94.84
Aprire:
$92.71
Volume 24 ore:
15.18M
Relative Volume:
1.49
Capitalizzazione di mercato:
$123.27B
Reddito:
$18.44B
Utile/perdita netta:
$5.36B
Rapporto P/E:
23.17
EPS:
4.16
Flusso di cassa netto:
$5.41B
1 W Prestazione:
-0.61%
1M Prestazione:
-0.45%
6M Prestazione:
+18.90%
1 anno Prestazione:
+16.06%
Intervallo 1D:
$92.47
$96.66
Intervallo di 1 settimana:
$90.73
$100.65
Portata 52W:
$56.32
$102.59
Lam Research Corp Stock (LRCX) Company Profile
Nome
Lam Research Corp
Settore
Industria
Telefono
(510) 659-0200
Indirizzo
4650 CUSHING BLVD, FREMONT, CA
Confronta LRCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
96.37 | 120.33B | 18.44B | 5.36B | 5.41B | 4.16 |
|
ASML
Asml Holding Nv
|
689.82 | 273.16B | 34.95B | 10.67B | 9.97B | 27.22 |
|
AMAT
Applied Materials Inc
|
179.99 | 144.50B | 28.09B | 6.76B | 5.86B | 8.22 |
|
KLAC
Kla Corp
|
886.64 | 116.24B | 11.55B | 3.70B | 3.51B | 27.51 |
|
TER
Teradyne Inc
|
104.16 | 17.23B | 2.91B | 577.07M | 608.44M | 3.54 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | Goldman | Buy |
| 2025-04-24 | Reiterato | TD Cowen | Buy |
| 2025-03-20 | Ripresa | Oppenheimer | Outperform |
| 2025-02-20 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2025-01-30 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Iniziato | Cleveland Research | Neutral |
| 2024-08-01 | Reiterato | TD Cowen | Buy |
| 2024-05-13 | Iniziato | Jefferies | Buy |
| 2024-04-25 | Reiterato | TD Cowen | Buy |
| 2024-04-19 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Reiterato | Needham | Buy |
| 2024-04-16 | Iniziato | Evercore ISI | Outperform |
| 2024-04-11 | Ripresa | Deutsche Bank | Hold |
| 2024-01-25 | Reiterato | TD Cowen | Outperform |
| 2024-01-23 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Iniziato | Redburn Atlantic | Buy |
| 2023-10-17 | Iniziato | Raymond James | Outperform |
| 2023-10-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-15 | Iniziato | Wolfe Research | Outperform |
| 2023-07-24 | Reiterato | Mizuho | Buy |
| 2023-07-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-04-20 | Reiterato | Berenberg | Buy |
| 2023-04-20 | Reiterato | Evercore ISI | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Jefferies | Buy |
| 2023-04-20 | Reiterato | Mizuho | Buy |
| 2023-04-20 | Reiterato | Stifel | Hold |
| 2023-04-20 | Reiterato | Wells Fargo | Equal Weight |
| 2023-03-13 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Ripresa | Stifel | Hold |
| 2022-12-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Reiterato | B. Riley Securities | Neutral |
| 2022-10-20 | Reiterato | BofA Securities | Buy |
| 2022-10-20 | Reiterato | DA Davidson | Neutral |
| 2022-10-20 | Reiterato | Evercore ISI | Outperform |
| 2022-10-20 | Reiterato | JP Morgan | Overweight |
| 2022-10-20 | Reiterato | Jefferies | Buy |
| 2022-10-20 | Aggiornamento | Summit Insights | Hold → Buy |
| 2022-10-20 | Reiterato | Wells Fargo | Equal Weight |
| 2022-07-25 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Reiterato | Barclays | Overweight |
| 2022-01-27 | Reiterato | Deutsche Bank | Hold |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | Susquehanna | Neutral |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2022-01-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Reiterato | Barclays | Overweight |
| 2022-01-10 | Reiterato | BofA Securities | Buy |
| 2022-01-05 | Ripresa | Jefferies | Buy |
| 2021-12-15 | Reiterato | Deutsche Bank | Hold |
| 2021-10-21 | Reiterato | B. Riley Securities | Buy |
| 2021-10-21 | Downgrade | Summit Insights | Buy → Hold |
| 2021-10-15 | Iniziato | Piper Sandler | Neutral |
| 2021-09-14 | Downgrade | Susquehanna | Positive → Neutral |
| 2021-09-07 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Reiterato | Mizuho | Buy |
| 2021-07-29 | Reiterato | Stifel | Buy |
| 2021-07-29 | Reiterato | UBS | Buy |
| 2021-07-29 | Reiterato | Wells Fargo | Equal Weight |
| 2021-03-31 | Iniziato | Bernstein | Outperform |
| 2021-01-28 | Reiterato | Cowen | Outperform |
| 2021-01-08 | Downgrade | Needham | Buy → Hold |
| 2020-12-17 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Reiterato | Goldman | Buy |
| 2020-10-22 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Reiterato | Mizuho | Buy |
| 2020-10-22 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-22 | Reiterato | Stifel | Buy |
| 2020-10-22 | Reiterato | UBS | Buy |
| 2020-09-21 | Aggiornamento | Stifel | Hold → Buy |
| 2020-07-30 | Reiterato | Cowen | Outperform |
| 2020-07-21 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Downgrade | Stifel | Buy → Hold |
| 2020-06-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Iniziato | Barclays | Overweight |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-04-08 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-04-03 | Aggiornamento | Nomura | Neutral → Buy |
| 2020-04-02 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-03-27 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Aggiornamento | UBS | Sell → Buy |
Mostra tutto
Lam Research Corp Borsa (LRCX) Ultime notizie
Cozad Asset Management Inc. Increases Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research (NASDAQ:LRCX) Price Target Raised to $113.00 - MarketBeat
Marco Investment Management LLC Sells 40,000 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research price target raised to $120 from $105 at Argus - TipRanks
Lam Research Corporation (LRCX) Reports Fourth-Quarter 2025 Results; Mizuho Raises PT to $120 - Insider Monkey
Should I hold or sell Lam Research Corporation stock in 2025Stock Market Opportunities For Beginners - jammulinksnews.com
Lam Research Corporation (NASDAQ:LRCX) Q4 2025 Earnings Call Transcript - Insider Monkey
Jim Cramer: This Consumer Defensive Stock Is 'Pretty Expensive' - Benzinga
Lam Research Corporation (NASDAQ:LRCX) Shares Purchased by Baker Avenue Asset Management LP - MarketBeat
Norden Group LLC Has $4.52 Million Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Acquired by Pinnacle Wealth Management Advisory Group LLC - MarketBeat
Foundations Investment Advisors LLC Cuts Stock Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corp Shines in Earnings Call - TipRanks
Lam Research (NASDAQ:LRCX) Shares Down 4.4%Here's Why - MarketBeat
Why Is Lam Research Stock Falling Thursday?Lam Research (NASDAQ:LRCX) - Benzinga
Lam Research (NASDAQ:LRCX) Given New $94.00 Price Target at Morgan Stanley - MarketBeat
Lam Research's Q4 Earnings Beat Expectations, Revenues Rise Y/Y - Yahoo.co
Needham & Company LLC Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock - MarketBeat
Lam Research Blows FY2025 Out Of The Water But AH Trading Shows Caution (NASDAQ:LRCX) - Seeking Alpha
Needham raises Lam Research stock price target to $115 on China demand By Investing.com - Investing.com South Africa
Needham raises Lam Research stock price target to $115 on China demand - Investing.com UK
FourThought Financial Partners LLC Sells 7,582 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Acquired by Arkadios Wealth Advisors - MarketBeat
NorthRock Partners LLC Boosts Stake in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Sold by Mackenzie Financial Corp - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Purchased by LPL Financial LLC - MarketBeat
Federated Hermes Inc. Raises Stock Holdings in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Meeder Asset Management Inc. Sells 13,551 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Lam Research Stock Dips Over 5% In Premarket Trading: What's Happening? - Benzinga
Summit Insights downgrades Lam Research stock rating to Hold from Buy By Investing.com - Investing.com South Africa
Summit Insights downgrades Lam Research stock rating to Hold from Buy - Investing.com UK
Lam Research: Fiscal Q4 Earnings Snapshot - CTPost
Lam Research Reports Strong Q2 2025 Earnings - TipRanks
Lam’s Wide Moat in Chip Equipment Positions It Well to Capture AI and Memory Spending - Morningstar
Lam Research (NASDAQ:LRCX) Releases Q1 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Lam Research Q4 2025 beats expectations, stock rises - Investing.com Nigeria
Zurcher Kantonalbank Zurich Cantonalbank Has $45.73 Million Stake in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Q2 2025 slides: record EPS, gross margin exceeds 50% - Investing.com
Lam Research (LRCX) Q4 Earnings and Revenues Top Estimates - Yahoo.co
Lam Research shares rise as Q4 results, guidance top expectations - Investing.com
Lam Research Corporation Reports Financial Results for the Quarter Ended June 29, 2025 - TradingView
Lam Research Corp (LRCX) Q2 Earnings: EPS of $1.35 Beats Estimates, Revenue Hits $5.17 Billion - GuruFocus
Lam Research (NASDAQ:LRCX) Stock Price Up 1.4%Here's Why - MarketBeat
Live Analysis: Lam Research (LRCX) Earnings Drop After the Bell - 24/7 Wall St.
Ultra Clean Posts Q2 Revenue Beat - The Motley Fool
Lam Research Corporation (NASDAQ:LRCX) Shares Bought by Tower Bridge Advisors - MarketBeat
Allium Financial Advisors LLC Purchases Shares of 7,780 Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Applied Finance Capital Management LLC Buys 2,713 Shares of Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corporation (NASDAQ:LRCX) Shares Bought by TD Asset Management Inc - MarketBeat
AE Wealth Management LLC Has $2.70 Million Position in Lam Research Corporation (NASDAQ:LRCX) - MarketBeat
Lam Research Corp Azioni (LRCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):